SidaSubSaharaV1, PubMed, Curation, bibRecord, 001540

Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.

Identifieur interne : 001540 ( PubMed/Curation ); précédent : 001539; suivant : 001541

Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.

Auteurs : Barbara Laughton [Afrique du Sud] ; Morna Cornell ; Michael Boivin ; Annelies Van Rie

Source :

Journal of the International AIDS Society [ 1758-2652 ] ; 2013.

RBID : pubmed:23782482

Descripteurs français

KwdFr :
- Adolescent, Agents antiVIH (effets indésirables), Agents antiVIH (usage thérapeutique), Démence associée au SIDA (anatomopathologie), Démence associée au SIDA (épidémiologie), Enfant, Humains, Infections à VIH (), Infections à VIH (anatomopathologie), Infections à VIH (traitement médicamenteux), Maladies du système nerveux (anatomopathologie), Maladies du système nerveux (épidémiologie), Système nerveux central ().
MESH :
- anatomopathologie : Démence associée au SIDA, Infections à VIH, Maladies du système nerveux.
- effets indésirables : Agents antiVIH.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Agents antiVIH.
- épidémiologie : Démence associée au SIDA, Maladies du système nerveux.
- Adolescent, Enfant, Humains, Infections à VIH, Système nerveux central.

English descriptors

KwdEn :
- AIDS Dementia Complex (epidemiology), AIDS Dementia Complex (pathology), Adolescent, Anti-HIV Agents (adverse effects), Anti-HIV Agents (therapeutic use), Central Nervous System (drug effects), Child, HIV Infections (complications), HIV Infections (drug therapy), HIV Infections (pathology), Humans, Nervous System Diseases (epidemiology), Nervous System Diseases (pathology).
MESH :
- chemical , adverse effects : Anti-HIV Agents.
- complications : HIV Infections.
- drug effects : Central Nervous System.
- drug therapy : HIV Infections.
- epidemiology : AIDS Dementia Complex, Nervous System Diseases.
- pathology : AIDS Dementia Complex, HIV Infections, Nervous System Diseases.
- chemical , therapeutic use : Anti-HIV Agents.
- Adolescent, Child, Humans.

Abstract

Globally, an estimated 3.4 million children are living with HIV, yet little is known about the effects of HIV and antiretroviral treatment (ART) on the developing brain, and the neurodevelopmental and behavioural outcomes of perinatally HIV-infected (PHIV+) adolescents. We reviewed the literature on neurodevelopmental outcomes in PHIV+ children and adolescents, and summarized the current evidence on behaviour, general cognition, specific domains, hearing and language, school performance and physical disabilities due to neurological problems. Evidence suggests that PHIV+ children do not perform as well as controls on general cognitive tests, processing speed and visual-spatial tasks, and are at much higher risk for psychiatric and mental health problems. Children with AIDS-defining diagnoses are particularly at risk for poorer outcomes. A striking finding is the lack of published data specific to the adolescent age group (10-25 years), particularly from resource-constrained countries, which have the highest HIV prevalence. In addition, extreme heterogeneity in terms of timing and source of infection, and antiretroviral experience limits our ability to summarize findings of studies and generalize results to other settings. Due to the complex nature of the developing adolescent brain, environmental influences and variation in access to ART, there is an urgent need for research on the longitudinal trajectory of neurodevelopment among children and adolescents perinatally infected with HIV, especially in high burden resource-constrained settings.

PubMed: 23782482

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001540

Links to Exploration step

pubmed:23782482

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.</title>
<author><name sortKey="Laughton, Barbara" sort="Laughton, Barbara" uniqKey="Laughton B" first="Barbara" last="Laughton">Barbara Laughton</name>
<affiliation wicri:level="1"><nlm:affiliation>Children's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. BL2@sun.ac.za</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Children's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cornell, Morna" sort="Cornell, Morna" uniqKey="Cornell M" first="Morna" last="Cornell">Morna Cornell</name>
</author>
<author><name sortKey="Boivin, Michael" sort="Boivin, Michael" uniqKey="Boivin M" first="Michael" last="Boivin">Michael Boivin</name>
</author>
<author><name sortKey="Van Rie, Annelies" sort="Van Rie, Annelies" uniqKey="Van Rie A" first="Annelies" last="Van Rie">Annelies Van Rie</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23782482</idno>
<idno type="pmid">23782482</idno>
<idno type="wicri:Area/PubMed/Corpus">001540</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001540</idno>
<idno type="wicri:Area/PubMed/Curation">001540</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001540</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.</title>
<author><name sortKey="Laughton, Barbara" sort="Laughton, Barbara" uniqKey="Laughton B" first="Barbara" last="Laughton">Barbara Laughton</name>
<affiliation wicri:level="1"><nlm:affiliation>Children's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. BL2@sun.ac.za</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Children's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cornell, Morna" sort="Cornell, Morna" uniqKey="Cornell M" first="Morna" last="Cornell">Morna Cornell</name>
</author>
<author><name sortKey="Boivin, Michael" sort="Boivin, Michael" uniqKey="Boivin M" first="Michael" last="Boivin">Michael Boivin</name>
</author>
<author><name sortKey="Van Rie, Annelies" sort="Van Rie, Annelies" uniqKey="Van Rie A" first="Annelies" last="Van Rie">Annelies Van Rie</name>
</author>
</analytic>
<series><title level="j">Journal of the International AIDS Society</title>
<idno type="eISSN">1758-2652</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS Dementia Complex (epidemiology)</term>
<term>AIDS Dementia Complex (pathology)</term>
<term>Adolescent</term>
<term>Anti-HIV Agents (adverse effects)</term>
<term>Anti-HIV Agents (therapeutic use)</term>
<term>Central Nervous System (drug effects)</term>
<term>Child</term>
<term>HIV Infections (complications)</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (pathology)</term>
<term>Humans</term>
<term>Nervous System Diseases (epidemiology)</term>
<term>Nervous System Diseases (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Agents antiVIH (effets indésirables)</term>
<term>Agents antiVIH (usage thérapeutique)</term>
<term>Démence associée au SIDA (anatomopathologie)</term>
<term>Démence associée au SIDA (épidémiologie)</term>
<term>Enfant</term>
<term>Humains</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (anatomopathologie)</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Maladies du système nerveux (anatomopathologie)</term>
<term>Maladies du système nerveux (épidémiologie)</term>
<term>Système nerveux central ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-HIV Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Démence associée au SIDA</term>
<term>Infections à VIH</term>
<term>Maladies du système nerveux</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Central Nervous System</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Agents antiVIH</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>AIDS Dementia Complex</term>
<term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>AIDS Dementia Complex</term>
<term>HIV Infections</term>
<term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Démence associée au SIDA</term>
<term>Maladies du système nerveux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Child</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Enfant</term>
<term>Humains</term>
<term>Infections à VIH</term>
<term>Système nerveux central</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Globally, an estimated 3.4 million children are living with HIV, yet little is known about the effects of HIV and antiretroviral treatment (ART) on the developing brain, and the neurodevelopmental and behavioural outcomes of perinatally HIV-infected (PHIV+) adolescents. We reviewed the literature on neurodevelopmental outcomes in PHIV+ children and adolescents, and summarized the current evidence on behaviour, general cognition, specific domains, hearing and language, school performance and physical disabilities due to neurological problems. Evidence suggests that PHIV+ children do not perform as well as controls on general cognitive tests, processing speed and visual-spatial tasks, and are at much higher risk for psychiatric and mental health problems. Children with AIDS-defining diagnoses are particularly at risk for poorer outcomes. A striking finding is the lack of published data specific to the adolescent age group (10-25 years), particularly from resource-constrained countries, which have the highest HIV prevalence. In addition, extreme heterogeneity in terms of timing and source of infection, and antiretroviral experience limits our ability to summarize findings of studies and generalize results to other settings. Due to the complex nature of the developing adolescent brain, environmental influences and variation in access to ART, there is an urgent need for research on the longitudinal trajectory of neurodevelopment among children and adolescents perinatally infected with HIV, especially in high burden resource-constrained settings.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23782482</PMID>
<DateCreated><Year>2013</Year>
<Month>06</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted><Year>2013</Year>
<Month>11</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1758-2652</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<PubDate><Year>2013</Year>
<Month>Jun</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>Journal of the International AIDS Society</Title>
<ISOAbbreviation>J Int AIDS Soc</ISOAbbreviation>
</Journal>
<ArticleTitle>Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.</ArticleTitle>
<Pagination><MedlinePgn>18603</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7448/IAS.16.1.18603</ELocationID>
<Abstract><AbstractText>Globally, an estimated 3.4 million children are living with HIV, yet little is known about the effects of HIV and antiretroviral treatment (ART) on the developing brain, and the neurodevelopmental and behavioural outcomes of perinatally HIV-infected (PHIV+) adolescents. We reviewed the literature on neurodevelopmental outcomes in PHIV+ children and adolescents, and summarized the current evidence on behaviour, general cognition, specific domains, hearing and language, school performance and physical disabilities due to neurological problems. Evidence suggests that PHIV+ children do not perform as well as controls on general cognitive tests, processing speed and visual-spatial tasks, and are at much higher risk for psychiatric and mental health problems. Children with AIDS-defining diagnoses are particularly at risk for poorer outcomes. A striking finding is the lack of published data specific to the adolescent age group (10-25 years), particularly from resource-constrained countries, which have the highest HIV prevalence. In addition, extreme heterogeneity in terms of timing and source of infection, and antiretroviral experience limits our ability to summarize findings of studies and generalize results to other settings. Due to the complex nature of the developing adolescent brain, environmental influences and variation in access to ART, there is an urgent need for research on the longitudinal trajectory of neurodevelopment among children and adolescents perinatally infected with HIV, especially in high burden resource-constrained settings.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laughton</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Children's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. BL2@sun.ac.za</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cornell</LastName>
<ForeName>Morna</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Boivin</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Van Rie</LastName>
<ForeName>Annelies</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>06</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>J Int AIDS Soc</MedlineTA>
<NlmUniqueID>101478566</NlmUniqueID>
<ISSNLinking>1758-2652</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 May 15;24(8):1163-70</RefSource>
<PMID Version="1">20425886</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropediatrics. 2003 Aug;34(4):177-81</RefSource>
<PMID Version="1">12973657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2012 May 15;26(8):959-69</RefSource>
<PMID Version="1">22382148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Soc Sci Med. 2011 Sep;73(5):693-701</RefSource>
<PMID Version="1">21840634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prog Brain Res. 2009;178:113-35</RefSource>
<PMID Version="1">19874965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Adolesc Health. 2012 Sep;51(3):242-51</RefSource>
<PMID Version="1">22921134</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Annu Rev Med. 2010;61:169-85</RefSource>
<PMID Version="1">19622036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2004 Dec 1;39(11):1692-8</RefSource>
<PMID Version="1">15578372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2010 Jul 15;51(2):214-24</RefSource>
<PMID Version="1">20536367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pediatr Psychol. 2001 Sep;26(6):321-9</RefSource>
<PMID Version="1">11490033</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pediatr Infect Dis J. 2012 Jun;31(6):592-8</RefSource>
<PMID Version="1">22592486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Rev. 2008;28(1):62-77</RefSource>
<PMID Version="1">18688292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pediatr. 2005 Mar;146(3):402-7</RefSource>
<PMID Version="1">15756229</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Perspect Psychol Sci. 2006 Mar;1(1):59-67</RefSource>
<PMID Version="1">26151185</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1990 Sep;28(3):303-11</RefSource>
<PMID Version="1">2241113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Int AIDS Soc. 2010;13 Suppl 2:S2</RefSource>
<PMID Version="1">20573284</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Psychol. 2007 Nov;43(6):1428-46</RefSource>
<PMID Version="1">18020822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Arch Otorhinolaryngol. 2011 Oct;268(10):1527-32</RefSource>
<PMID Version="1">21437696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Pediatr Adolesc Med. 2005 Jul;159(7):651-6</RefSource>
<PMID Version="1">15996999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Neuropsychol. 2006;30(2):633-57</RefSource>
<PMID Version="1">16995830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2010 Jan;35(1):147-68</RefSource>
<PMID Version="1">19794405</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prev Chronic Dis. 2007 Oct;4(4):A107</RefSource>
<PMID Version="1">17875251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):296-312</RefSource>
<PMID Version="1">16492261</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2012 Apr;54(7):1001-9</RefSource>
<PMID Version="1">22308272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2008 Jul;20(6):692-9</RefSource>
<PMID Version="1">18576171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2013;25(2):160-8</RefSource>
<PMID Version="1">22690655</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2004 Oct 2-8;364(9441):1236-43</RefSource>
<PMID Version="1">15464184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Health Psychol. 1995 Jan;14(1):13-21</RefSource>
<PMID Version="1">7737068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Neuropsychol. 2002;21(3):223-41</RefSource>
<PMID Version="1">12233936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Acad Child Adolesc Psychiatry. 2009 Aug;48(8):810-9</RefSource>
<PMID Version="1">19564801</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2009 Sep 10;23(14):1893-901</RefSource>
<PMID Version="1">19644348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Med Child Neurol. 2002 Jan;44(1):4-16</RefSource>
<PMID Version="1">11811649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2010 Feb;7(2):e1000227</RefSource>
<PMID Version="1">20161804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Dev Behav Pediatr. 2012 Feb;33(2):112-23</RefSource>
<PMID Version="1">22179050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(11):e7898</RefSource>
<PMID Version="1">19936066</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Trop Pediatr. 2010 Dec;56(6):421-6</RefSource>
<PMID Version="1">20167634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2010 Nov;55(3):380-90</RefSource>
<PMID Version="1">20802343</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2009 Sep 10;23(14):1859-65</RefSource>
<PMID Version="1">19584705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Patient Care STDS. 2010 Mar;24(3):141-6</RefSource>
<PMID Version="1">20214481</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurovirol. 2012 Jun;18(3):205-12</RefSource>
<PMID Version="1">22552809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2012;24(1):119-28</RefSource>
<PMID Version="1">21854350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2011 Apr;23(4):401-12</RefSource>
<PMID Version="1">21271393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 Jun 19;24(10):1481-91</RefSource>
<PMID Version="1">20539091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2012;24(8):953-62</RefSource>
<PMID Version="1">22519762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychology. 2010 Sep;24(5):667-73</RefSource>
<PMID Version="1">20804255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 2009 Aug;124(2):627-36</RefSource>
<PMID Version="1">19596734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Behav. 2013 Mar;17(3):976-86</RefSource>
<PMID Version="1">21842420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Otolaryngol Head Neck Surg. 2012 Feb;146(2):259-65</RefSource>
<PMID Version="1">22128111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pediatr Infect Dis J. 2013 May;32(5):501-8</RefSource>
<PMID Version="1">23263176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2010 Sep;55(1):134-6</RefSource>
<PMID Version="1">20733406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Behav Neurosci. 2011 Dec;125(6):970-8</RefSource>
<PMID Version="1">22004262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Dev Behav Pediatr. 1998 Feb;19(1):18-25</RefSource>
<PMID Version="1">9524301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Paediatr Neurol. 2008 Jul;12(4):290-7</RefSource>
<PMID Version="1">17950012</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Educ Prev. 2011 Jun;23(3):222-35</RefSource>
<PMID Version="1">21696241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94</RefSource>
<PMID Version="1">20035164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Soc Work. 2008 Oct;53(4):307-16</RefSource>
<PMID Version="1">18853667</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2006 Dec;253(12):1615-24</RefSource>
<PMID Version="1">17093898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Cogn Sci. 2005 Feb;9(2):69-74</RefSource>
<PMID Version="1">15668099</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Dev Behav Pediatr. 2013 May;34(4):269-78</RefSource>
<PMID Version="1">23535340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Clin Neuropsychol. 1987;2(3):245-56</RefSource>
<PMID Version="1">14589616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Child Dev. 2007 Nov-Dec;78(6):1760-70</RefSource>
<PMID Version="1">17988319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Child Neurol. 2011 Nov;26(11):1355-64</RefSource>
<PMID Version="1">21616924</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Patient Care STDS. 2009 Jun;23(6):415-21</RefSource>
<PMID Version="1">19415986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Pediatr Adolesc Med. 2012 Jun 1;166(6):528-35</RefSource>
<PMID Version="1">22312169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Adolesc Health. 2009 Aug;45(2):133-41</RefSource>
<PMID Version="1">19628139</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Child Psychol Psychiatry. 2013 Apr;54(4):423-44</RefSource>
<PMID Version="1">22943414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pediatr Infect Dis J. 2012 Aug;31(8):835-41</RefSource>
<PMID Version="1">22549437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Patient Care STDS. 2011 Aug;25(8):493-501</RefSource>
<PMID Version="1">21745118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Opin Obstet Gynecol. 2011 Oct;23(5):321-7</RefSource>
<PMID Version="1">21836510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 2006 Mar;117(3):729-40</RefSource>
<PMID Version="1">16510653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2011 Dec;23(12):1533-44</RefSource>
<PMID Version="1">21702707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Dev Behav Pediatr. 2010 Feb-Mar;31(2):116-28</RefSource>
<PMID Version="1">20110828</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Behav Modif. 1997 Oct;21(4):409-32</RefSource>
<PMID Version="1">9337599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Child Dev Behav. 2009;37:233-78</RefSource>
<PMID Version="1">19673164</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015526" MajorTopicYN="N">AIDS Dementia Complex</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3687073</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adolescents</Keyword>
<Keyword MajorTopicYN="N">children</Keyword>
<Keyword MajorTopicYN="N">executive function</Keyword>
<Keyword MajorTopicYN="N">hearing</Keyword>
<Keyword MajorTopicYN="N">neurocognitive</Keyword>
<Keyword MajorTopicYN="N">neurodevelopment</Keyword>
<Keyword MajorTopicYN="N">neurological</Keyword>
<Keyword MajorTopicYN="N">perinatally HIV infected</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>02</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>04</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>04</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>6</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>6</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>11</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23782482</ArticleId>
<ArticleId IdType="pii">18603</ArticleId>
<ArticleId IdType="pmc">PMC3687073</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001540 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001540 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:23782482
   |texte=   Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:23782482" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaSubSaharaV1

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024

	Le SIDA en Afrique subsaharienne (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA en Afrique subsaharienne (serveur d'exploration)

Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.

Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki